291.1Integrating Clinical and immune response Biomarkers to Understand kidney Graft recipient’s risk of infection (the IC-BUG study)
Matthew Rowlandson (AU)
Infectious complications in solid organ transplantation
Presentations
Oral Presentation
Mini-Oral Presentation
291.2From exclusion to opportunity: Rethinking contraindications in organ donation. A 5-Year UAE analysis
Reginaldo Boni (AE)
291.3Multidrug-resistant donor-derived infections in solid organ transplantation: a systematic review and meta-analysis of transmission risk factors
Carolina Lopes (BR)
291.4Invasive fungal infections in heart transplants: A ten-year, single centre experience from subtropical Australia
Kanthi Vemuri (AU)
291.510-year cohort of donor-derived disease in solid organ transplantation in Germany from 2016-2025
Ana Paula Barreiros (DE)
291.6Evaluation of empiric intraoperative antibiotic regimens for coverage of donor-derived infection in lung transplantation: A single-center retrospective study
Zhenyu Zhang (CN)
291.7Parasitic infection related organ failure and transplantation: A systematic review and individual patient data meta-analysis
Tuerhongjiang Tuxun (CN)
291.8Identification and validation of clinical phenotypes in liver transplant donors and recipients to predict early mortality and infections
Cecilia Bonazzetti (IT)
Rapid-Fire Presentation
291.9Legionella pneumonia: Comparison between solid organ transplant and hematopoietic stem cell transplant recipients
Holenarasipur Vikram (US)
291.10High burden of tuberculosis and invasive fungal infections after heart transplantation in TB-endemic setting: a 20-year cohort from Thailand
Pakpoom Phoompoung (TH)
291.12When CMV mismatch meets demographics: CMV donor/recipient serostatus and mortality after liver transplantation
Maheen Abidi (US)
291.13EBV mismatch in kidney transplantation: rates of viraemia, seroconversion and post-transplant lymphoproliferative disorder
Janine Miranda (NZ)